Office for Life Sciences

Last updated

Office for Life Sciences
AbbreviationOLS
Formation2009
Legal statusGovernment unit
PurposeGovernment advisory for life sciences policy
Region served
United Kingdom
Director
Roz Campion
Affiliations Department for Science, Innovation and Technology Department of Health and Social Care
Website www.gov.uk/government/organisations/office-for-life-sciences OOjs UI icon edit-ltr-progressive.svg

The Office for Life Sciences (OLS) is part of the British government. The organisation supports the delivery of the UK Government's life sciences and innovation policy by connecting decision making across government. [1] Informed by productive engagement with industry, the OLS promotes research, innovation, and technology within government for the improvement of healthcare. [2] [3]

Contents

The office sits across the Department for Science, Innovation and Technology and the Department of Health and Social Care, [4] reporting to the Minister for Science, Research and Innovation and the Minister for Health and Secondary Care. The work of the OLS is held to account by the UK Parliament, including the Science, Innovation and Technology Select Committee, and the Health and Social Care Select Committee.

History

The Office for Life Sciences was created in 2009 following an announcement by UK Prime Minister Gordon Brown on the establishment of a new cross-government unit to drive forward innovation within the healthcare system, and to support national policy making on the UK's attractiveness as a market for medicines and medical devices and technologies. [1] [5] The OLS was supported through its inception by Lord Drayson as Minister of State for Science and Innovation. [6]

Leadership

The Office for Life Sciences is a joint-government office of the Department for Science, Innovation and Technology and the Department of Health and Social Care, and is answerable to government ministers.

The OLS is headed up by civil servants, with the leadership as follows:

PositionNameTenure
DirectorKristen McLeod [7] October 2017 - November 2021
Rosalind CampionNovember 2021 - present

Strategy

Life Sciences Blueprint (2009–2010)

The Life Sciences Blueprint, published in July 2009, set out a vision for UK life sciences policy which the OLS was tasked with supporting. The blueprint focused on: [8]

Strategy for UK Life Sciences (2011–2017)

The Strategy for UK Life Sciences was published in December 2011 and led by the Department for Business, Innovation and Skills and Department of Health. [9] The paper was one of the first policy documents on life sciences under the Conservative-Liberal Democrat coalition government, which expanded upon the work of the previous Labour administration in building the UK's life sciences clout. [10] The strategy outlined an agenda for regulatory and medicines access reform to boost UK attractiveness and to deliver greater innovation within the NHS and the wider healthcare system. [9] [10] [11]

Life Sciences Industrial Strategy (2017–2021)

The UK's Industrial Strategy [12] is a core legacy of Theresa May's premiership which sets out a move towards a more interventionist industrial agenda than that of her Conservative predecessors. [13] [14] With life sciences recognised as a key sector of the Industrial Strategy, Professor Sir John Bell was asked to formulate a specific strategy for the sector. [15] The Life Sciences Industrial Strategy was split into seven main themes and made several recommendations to expand and grow the UK's scientific and research base. [15]

The Life Sciences Industrial Strategy was accompanied by two negotiated 'sector deals', a type of bespoke arrangement between government and industry, [13] which agreed specific-shared innovation priorities, including the commitment to scale-up the UK's genomic sequencing capabilities. [13] In January 2020, an update to the strategy was published by the UK Government which examined the progress to date in achieving the 2017 vision. [16]

Life Sciences Vision (2021–present)

In March 2021, it was announced that the UK Government would introduce a new plan for growth to replace the Industrial Strategy. [17] In an open letter to businesses, Chancellor Rishi Sunak and Business Secretary Kwasi Kwarteng set out the government's vision for the Plan for Growth [18] which would take advantage of COVID-19 recovery planning to deliver the ambitions of the 2019 Conservative Party manifesto. The plan is the legacy of Downing Street advisor Dominic Cummings which seeks to place technology and innovation at the heart of the UK’s economic future. [17] The Plan for Growth continues elements of the Industrial Strategy, including the Life Science Sector Deals, and policy specific proposals would be made within 12 months of its publication. [18]

Following the publication of the Plan for Growth, the UK Government published the Life Sciences Vision in July 2021 which set out a policy specific framework for the government's approach to life sciences policy. [19] At the centre of the framework is the vision to make the UK the globally leading location for life sciences within a decade, by 2031. [20]

It sets out three core collaborative ambitions: [19]

It sets out seven healthcare missions (eight combined with the government's drug strategy) for the sector to ecourage innovation and address unmet clinical need: [19] [20]

  1. Improving translational capabilities in neurodegeneration and dementia
  2. Enabling early diagnosis and treatments, including immune therapies such as cancer vaccines
  3. Sustaining the UK position in novel vaccine discovery development and manufacturing
  4. Treatment and prevention of cardiovascular diseases and its major risk factors, including obesity
  5. Reducing mortality and morbidity from respiratory disease in the UK and globally
  6. Addressing the underlying biology of ageing
  7. Increasing the understanding of mental health conditions, including work to redefine diseases and develop translational tools to address them.

The Life Sciences Vision sits within and underneath the overarching cross-governmental and cross-sector Plan for Growth. [19]

Work of the OLS

Life sciences indicators

Since 2015, the Office for Life Sciences has published data annually which assesses UK life science sector performance against international standards, practices, and trends. [21] The indicators cover the research environment, domestic market, production environment, international collaboration, investment environment, and access to skilled labour. [21]

The data is routinely used by policy makers to track sector performance. In July 2023, the UK's primary pharmaceutical representative body, the Association of the British Pharmaceutical Industry (ABPI), responded to a publication of the indicators and assessed that inward life sciences foreign direct investment (FDI) had fallen by 47% in 2022 compared to 2021, falling to £1 billion from £1.9 billion. [22]

Related Research Articles

<span class="mw-page-title-main">Economy of England</span>

The economy of England is the largest economy of the four countries of the United Kingdom. England's economy is one of the largest and most dynamic in the world, with an average GDP per capita of £37,852 in 2022.

Research funding is a term generally covering any funding for scientific research, in the areas of natural science, technology, and social science. Different methods can be used to disburse funding, but the term often connotes funding obtained through a competitive process, in which potential research projects are evaluated and only the most promising receive funding. It is often measured via Gross domestic expenditure on R&D (GERD).

<span class="mw-page-title-main">Association of the British Pharmaceutical Industry</span> British trade group

The Association of the British Pharmaceutical Industry (ABPI) is the trade association for over 120 companies in the UK producing prescription medicines for humans, founded in 1891. It is the British equivalent of America's PhRMA; however, the member companies research, develop, manufacture and supply medicines prescribed for the National Health Service.

<span class="mw-page-title-main">Ministry of Economy, Trade and Industry</span> Cabinet-level ministry of the Government of Japan

The Ministry of Economy, Trade and Industry, METI for short, is a ministry of the Government of Japan. It was created by the 2001 Central Government Reform when the Ministry of International Trade and Industry (MITI) merged with agencies from other ministries related to economic activities, such as the Economic Planning Agency.

<span class="mw-page-title-main">Healthcare in the United Kingdom</span>

Healthcare in the United Kingdom is a devolved matter, with England, Northern Ireland, Scotland and Wales each having their own systems of publicly funded healthcare, funded by and accountable to separate governments and parliaments, together with smaller private sector and voluntary provision. As a result of each country having different policies and priorities, a variety of differences have developed between these systems since devolution.

The National electronic Library for Health (NeLH) was a digital library service provided by the NHS for healthcare professionals and the public between 1998 and 2006. It briefly became the National Library for Health and elements of it continue to this day as NHS Evidence, managed by the National Institute for Health and Care Excellence, and a range of services provided by Health Education England's Library and Knowledge Service Leads.

The National Institute for Health and Care Research (NIHR) is the British government's major funder of clinical, public health, social care and translational research. With a budget of over £1.2 billion in 2020–21, its mission is to "improve the health and wealth of the nation through research". The NIHR was established in 2006 under the government's Best Research for Best Health strategy, and is funded by the Department of Health and Social Care. As a research funder and research partner of the NHS, public health and social care, the NIHR complements the work of the Medical Research Council. NIHR focuses on translational research, clinical research and applied health and social care research.

<span class="mw-page-title-main">Knowledge Quarter, Liverpool</span> Science and education district of Liverpool UK

The "Knowledge Quarter" is an area of Liverpool city centre covering 450 acres, incorporating the vicinity around London Road, Islington, the so called 'Fabric District', Paddington Village and part of Canning.

<span class="mw-page-title-main">Mariana Mazzucato</span> Italian-American economist and professor (born 1968)

Mariana Francesca Mazzucato is an Italian–American-British economist and academic. She is a professor in the Economics of Innovation and Public Value at University College London (UCL) and founding director of the UCL Institute for Innovation and Public Purpose (IIPP). She is best known for her work on dynamics of technological change, the role of the public sector in innovation, and the concept of value in economics. The New Republic have called her one of the "most important thinkers about innovation".

<span class="mw-page-title-main">Ministry of Business, Innovation and Employment</span> New Zealand government department

The Ministry of Business, Innovation and Employment is the public service department of New Zealand charged with "delivering policy, services, advice and regulation" which contribute to New Zealand's economic productivity and business growth.

Richard William Barker is the Founder of New Medicine Partners and Founding Director of the University of Oxford — University College of London Centre for the Advancement of Sustainable Medical Innovation (CASMI).

Innovation districts are urban geographies of innovation where R&D strong institutions, companies, and other private actors develop integrated strategies and solutions to develop thriving innovation ecosystems–areas that attract entrepreneurs, startups, and business incubators. Unlike science parks, innovation districts are physically compact, leverage density and high levels of accessibility, and provide a “mash up” of activities including housing, office, and neighborhood-serving amenities. Districts signify the collapse back of innovation into cities and is increasingly used as a way to revitalize the economies of cities and their broader regions. As of 2019, there are more than 100 districts worldwide.

<span class="mw-page-title-main">Department for Business, Energy and Industrial Strategy</span> Defunct department of the UK Government

The Department for Business, Energy, and Industrial Strategy (BEIS) was a ministerial department of the United Kingdom Government, from July 2016 to February 2023.

Brexit and arrangements for science and technology refers to arrangements affecting scientific research, experimental development and innovation that are within the scope of the negotiations between the United Kingdom and the European Union on the terms of Britain's withdrawal from the European Union (EU).

Science and technology in Botswana examines recent trends and developments in science, technology and innovation policy in this country. The Republic of Botswana was one of the first countries of the Southern African Development Community (SADC) to adopt a science and technology policy in 1998. This was later updated in 2011.

This article summarizes the development of science and technology in Cambodia from a policy perspective.

The 2020 New Year Honours are appointments by some of the 16 Commonwealth realms to various orders and honours to recognise and reward good works by citizens of those countries. The New Year Honours are awarded as part of the New Year celebrations at the start of January and were officially announced in The London Gazette on 27 December 2019. Australia, an independent Realm, has a separate honours system and its first honours of the year, the 2020 Australia Day Honours, coincide with Australia Day on 26 January.

<span class="mw-page-title-main">Minister of State for Science, Research and Innovation</span> Junior minister in the British Government

The minister of state for science, research and innovation is a mid-level position in the Department for Science, Innovation and Technology in the British government. It was re-created by the Second Johnson ministry out of the minister of state for universities.

<span class="mw-page-title-main">Parliamentary Under-Secretary of State for Technology, Innovation and Life Sciences</span> Junior minister in the British Government

The Parliamentary Under-Secretary of State for Technology, Innovation and Life Sciences was a junior position in the Department of Health and Social Care in the British government. It is currently vacant since 20 September 2022.

<span class="mw-page-title-main">Department for Science, Innovation and Technology</span> Ministerial department of the UK Government

The Department for Science, Innovation and Technology (DSIT) is a ministerial department of the Government of the United Kingdom. It was established on 7 February 2023 by a cabinet reshuffle under the Rishi Sunak premiership.

References

  1. 1 2 "Government creates Office for Life Sciences". PMLive. 6 April 2009. Retrieved 16 April 2021.
  2. ↑ "Our place in the UK research landscape". NIHR. Retrieved 16 April 2021.
  3. ↑ "Office for Life Sciences: About us". GOV.UK. Retrieved 16 April 2021.
  4. ↑ "Latest update from the Office for Life Sciences (OLS)". Medilink West Midlands. 7 February 2020. Retrieved 19 April 2021.
  5. ↑ Taylor, Lynne (7 April 2009). "UK's OLS "to make a real difference to pharma/biotech"". PharmaTimes. Retrieved 16 April 2021.
  6. ↑ "Lord Drayson on new technology that could power devices for free". www.managementtoday.co.uk. Retrieved 16 April 2021.
  7. ↑ "The Board | Genomics England". 2013-07-01. Retrieved 2021-04-21.
  8. ↑ "Departmental Report 2009" (PDF). GOV.UK. Department for Innovation, Universities and Skills. Retrieved 16 April 2021.
  9. 1 2 "Strategy for UK Life Sciences" (PDF). Department for Business, Innovation and Skills. December 2011. Retrieved 17 April 2021.
  10. 1 2 Philippidis, Alex (2012-01-16). "U.K. Counts on New Strategy to Push Biopharma Startups Past "Valley of Death"". GEN – Genetic Engineering and Biotechnology News. Retrieved 2021-04-17.
  11. ↑ "House of Commons Science and Technology Committee: Bridging the "valley of death": improving the commercialisation of research – Response by the Wellcome Trust" (PDF). Wellcome Trust. February 2012. Retrieved 17 April 2021.
  12. ↑ "Life Sciences Industrial Strategy" (PDF). Office for Life Sciences. 30 August 2017. Retrieved 17 April 2021.
  13. 1 2 3 "Research Briefing – Industrial strategy" (PDF). UK Parliament. House of Commons Library. 8 August 2019. Retrieved 17 April 2021.
  14. ↑ "Read Theresa May's keynote speech to the Conservative conference in full". The Independent. 2016-10-05. Retrieved 2021-04-17.
  15. 1 2 "Life Sciences Industrial Strategy". www.abpi.org.uk. Retrieved 2021-04-17.
  16. ↑ "Life sciences industrial strategy update". GOV.UK. Retrieved 2021-04-17.
  17. 1 2 "UK industrial strategy refresh ditched as ministers set out plan for growth". www.ft.com. Retrieved 18 April 2021.
  18. 1 2 "Letter from Chancellor Rishi Sunak and Business Secretary Kwasi Kwarteng to businesses on the government's Plan for Growth". GOV.UK. Retrieved 2021-04-18.
  19. 1 2 3 4 "Life Sciences Vision". GOV.UK. Retrieved 2023-12-10.
  20. 1 2 "Delivery of the life science vision healthcare missions" (PDF). NHS Accelerated Access Collaborative. NHS England. July 2022. Retrieved 10 December 2023.
  21. 1 2 "Life science sector data". GOV.UK. 2023-07-13. Retrieved 2023-12-10.
  22. ↑ "UK life science inward investment in freefall". www.abpi.org.uk. 2023-12-07. Retrieved 2023-12-10.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.